PLYMOUTH MEETING, PA, February 12, 2019 — Harmony Biosciences, LLC (Harmony), announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for its investigational product, pitolisant,…Original Article
Harmony Biosciences Announces File Acceptance Of Its New Drug Application For Pitolisant
